FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-9998com.
(The FASEB Journal. 2008;22:1606-1617.)
© 2008 FASEB
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.07-9998comv1
fj.07-9998comv2
22/5/1606    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dou, G.-R.
Right arrow Articles by Han, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dou, G.-R.
Right arrow Articles by Han, H.

RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice

Guo-Rui Dou*,{dagger},1, Yao-Chun Wang*,1, Xing-Bin Hu*,1, Li-Hong Hou*, Chun-Mei Wang*, Jian-Feng Xu{dagger}, Yu-Sheng Wang{dagger},1,2, Ying-Min Liang*,{dagger}, Li-Bo Yao*, An-Gang Yang* and Hua Han*,{ddagger},2

* State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology;

{dagger} Department of Ophthalmology, Xijing Hospital; and

{ddagger} Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi’an, China

2Correspondence: H.H., Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Chang-Le Xi St. #17, Xi’an 710032, China. E-mail: huahan{at}fmmu.edu.cn; Y.S.W., Department of Ophthalmology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China. E-mail: wangys{at}fmmu.edu.cn.com


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
In adults, angiogenic abnormalities are involved in not only tumor growth but several human inherited diseases as well. It is unclear, however, concerning how the normal vascular structure is maintained and how angiogenesis is initiated in normal adults. Using the Cre-LoxP-mediated conditional gene deletion, we show in the present study that in adult mice disruption of the transcription factor recombination signal-binding protein J{kappa} (RBP-J) in endothelial cells strikingly induced spontaneous angiogenesis in multiple tissues, including retina and cornea, as well as in internal organs, such as liver and lung. In a choroidal neovascularization model, which mimics the angiogenic process in tumor growth and age-related macular degeneration, RBP-J deficiency induced a more intensive angiogenic response to injury. This could be transmitted by bone marrow, indicating that RBP-J could modulate bone marrow-derived endothelial progenitor cells in adult angiogenesis. In addition, in the absence of RBP-J, proliferation of endothelial cells increased significantly, leading to accumulative vessel outgrowth. These findings suggest that in adults RBP-J-mediated Notch signaling may play an essential role in the maintenance of vascular homeostasis by repressing endothelial cell proliferation.—Dou, G.-R., Wang, Y.-C., Hu, X.-B., Hou, L.-H., Wang, C.-M., Xu, J.-F., Wang, Y.-S., Liang, Y.-M., Yao, L.-B., Yang, A.-G., Han, H. RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice.


Key Words: angiogenesis • Notch signaling • endothelial cells • choroidal neovascularization


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
BLOOD VESSELS PROVIDE NUTRIENTS and instructive signals for tissues in both embryonic and postnatal development. In embryonic and early postnatal stages, vessel precursors are progressively assembled by vasculogenesis and angiogenesis into a highly organized and functionally competent vascular network. These processes are believed to be halted in most adult tissues except for the ovaries and the uterus epithelium during the menstrual cycle, while potentials of both angiogenesis and vasculogenesis are retained throughout the life. Under normal physiological conditions, most mature endothelial cells (ECs) remain quiescent to maintain vascular homeostasis (1) . However, in some inherited abnormalities or in response to pathological stimuli such as trauma or malignant growth, mature ECs regain the ability of proliferating and remodeling, leading to neovascularization in adults. Notably, it is widely accepted at present that vasculogenesis also contributes to postnatal neovascularization through endothelial progenitor cells (EPCs; ref. 2 ). In many diseases such as ocular neovascularization and tumors, deteriorating destabilization of vascular homeostasis acts as an etiological clue or contributes to disease progression. Therefore, it is critical to understand the potential mechanisms controlling vascular homeostasis and angiogenesis/vasculogenesis in adults.

A number of signaling pathways are involved in the control of vessel growth and stability (3) . Notch signaling, an evolutionarily conserved pathway governing cell fate specification, plays a pivotal role in embryonic vascular development (4) . Notch ligands and receptors such as Delta-like (Dll) 4, Jagged1, Jagged2, Notch1, Notch2, and Notch4 are expressed by vascular endothelium and/or supporting cells (5 6 7) . Genetic inactivation of these ligands and receptors, or of other key components of the Notch pathway such as Hey1 (Hesr1) and Hey2 (Hesr2), leads to embryonic lethality in mice due to failures in vessel formation (9 10 11 12 13 14 15 16 17) . Cellular analyses have shown that in the absence of Notch signaling, vessel remodeling, the key step in angiogenesis, turns out to be defective, with embryonic vasculogenesis appearing intact. Notch signaling acts cell autonomously in ECs (18) . Recently, by using a zebra fish model and Dll4 haploinsufficient mice, several groups (19 , 20) have demonstrated that Notch signaling regulates angiogenesis during embryonic and early postnatal stages by restricting endothelial tip cell specification and behaviors. In addition, Notch signaling is essential for the establishment of arteriovenous identity. Endothelial expression of constitutively active Notch4 in adult endothelium causes artery-vein shunting and subsequent arteriovenous malformations (8) . In summary, Notch signaling participates in embryonic angiogenesis by establishing an arteriovenous identity and regulating endothelial tip cell specification and proliferation, leading to vascular remodeling (21) .

Although the Notch pathway is crucially implicated in embryonic vascularization, its function and mechanisms in the adult vascular system remain largely uninvestigated. The gene responsible for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a degenerative vascular disease characterized by recurrent subcortical ischemia and vascular dementia, has been mapped to Notch3, suggesting a noticeable role of Notch signaling in adult vascular stability (22) . Similarly, in Allagilles syndrome, haploinsufficiency of Jagged1 leads to inherited vascular anomalies (23) . Preferential expression of Notch pathway components in tumor ECs implicates their significance in pathological angiogenesis in adults (24) . This has been further supported by the reported results that blockade of Dll4 increases EC proliferation and tumor vascular density but inhibits tumor growth due to poor function of new vessels and studies taking Notch signaling as a new target of cancer therapy have been inspired ever since (25) . Furthermore, in vitro evidence has proven that Notch signaling may be involved in the transition of ECs from the state of proliferation to quiescence, a state recognized as differentiation-associated cell-cycle arrest, as well as vessel remodeling (20 , 26) . Also by using in vitro cultured ECs, Taylor et al. (27) have shown that Notch signaling is active in EC contact inhibition by providing negative signals on proliferation. Despite the above-mentioned results, the role of Notch signaling in maintaining the vasculature of adults is still unclear.

Recombination signal-binding protein J{kappa} (RBP-J), also named C-promoter binding factor1 (CBF1) in mammals and suppressor of hairless [Su(H)] in Drosophila melanogaster, is a DNA-binding protein recognizing a consensus sequence C(T)GTGGGAA and is one member of the CSL family of transcription factors. RBP-J primarily acts as a transcription repressor of promoters possessing RBP-J-binding sites by recruiting other corepressors. The most important function of RBP-J, however, is to mediate signals from Notch receptors (28) . On ligand binding, Notch signaling is initiated by {gamma}-secretase-mediated proteolytic cleavage and liberation of the Notch intracellular domain (NICD). NICD subsequently translocates into the nucleus where the interaction between NICD and RBP-J occurs, through which NICD activates the transcription of downstream genes. Interestingly, knockout of RBP-J resulted in embryonic failure with severe vascular phenotypes resembling those of the Notch1 Notch4 double mutants (29) . Vascular defects in endothelial-specific knockout of RBP-J embryos were more profound than those in embryos lacking Dll4, suggesting that additional Notch ligands may play important roles during early vascular development (30 , 31) .

In the present study, the function of RBP-J in adult angiogenesis was investigated using Cre-loxP-mediated conditional knockout mice (32) . The results have demonstrated that, when RBP-J was disrupted in ECs of adult mice, spontaneous angiogenesis occurred in multiple organs. In addition, loss of RBP-J in adults markedly enhanced neovascular outgrowth from the existing vessel network in vivo, as well as injury-induced angiogenesis. At the cellular level, RBP-J-deficient ECs exhibited hyperproliferating phenotypes. Finally, deletion of RBP-J in adult ECs led not only to the down-regulation of a series of downstream genes such as Hes1, Hesr1, and VEGFR1 but also to the up-regulation of VEGFR2 and p21WAF1. To summarize, our results suggested that in adults RBP-J-mediated Notch signaling may be a key element in the maintenance of vascular homeostasis.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Mice
Generation and genotyping of RBP-J-floxed (RBPf) mice, mating with MxCre transgenic mice, as well as induction with poly(I)-poly(C) (Sigma, St. Louis, MO, USA) were essentially as described previously (32) . ROSA26R mice were obtained from Jackson Laboratory (Bar Harbor, ME, USA). All mice were maintained in specific pathogen-free conditions. Mice used in the choroidal neovascularization (CNV) model were handled in accordance with guidelines from the Association for Research in Vision and Ophthalmology. All animal experiments were approved by the Animal Experiment Administration Committee of the Fourth Military Medical University.

Histology
Tissues were fixed in Bouin’s fixative or 4% paraformaldehyde, embedded in paraffin, sectioned at 6 µm, and stained with hematoxylin and eosin (H&E) by standard methods. Masson’s triple staining was also performed according to standard procedures. To examine LacZ expression, mouse ears and flat-mounted retinas were fixed in 0.25% glutaraldehyde/PBS for 5 min, rinsed three times, and stained at 37°C in the X-gal buffer (1.3 mg/ml potassium ferrocyanide, 0.2% Triton X-100, 1 mmol/L MgCl2, and 1 mg/ml X-gal in PBS) for 4 h.

For immunofluorescence, corneas and retinas were fixed overnight with 4% paraformaldehyde, flat-mounted, and immunostained with fluorescein isothiocyanate (FITC) -conjugated anti-CD31 (Chemicon International, Temecula, CA, USA) or anti- proliferating cell nuclear antigen (PCNA; Sigma). In some cases, rhodamine-labeled ricinus communis agglutinin l (Vector Laboratories, Burlingame, CA, USA) was used for staining. Images were taken using a fluorescence microscope (BX51, Olympus, Tokyo, Japan) with a CCD camera (DP70, Olympus) or a confocal microscope (FV1000, Olympus). In some experiments, pictures were imported into Image Pro Plus 5.1 software, and pixels for each color were analyzed to quantitatively represent positively stained cells.

Immunohistochemistry was performed by standard procedures with rat anti-mouse CD31 (Chemicon International, 1:500 dilution) or monoclonal anti-mouse VEGFR2 antibody (Chemicon International, 1:200 dilution) as primary antibodies. Secondary antibodies included goat anti-mouse IgG (Boster BioTec, Wuhan, China), biotinylated rabbit anti-rat IgG, and horseradish peroxidase-conjugated streptavidin (Zhongshanxinqiao, Beijing, China).

For scanning electron microscopy (SEM), tissues were washed in 0.1 M phosphate buffer, fixed with 2.5% glutaraldehyde for 24 h, and washed again in 0.1 M phosphate buffer. Tissues were then rinsed with distilled water and dehydrated with ethanol. Samples were coated with gold particles and examined under a scanning electron microscope (S-3400N, Hitachi, Japan).

Fluorescence-activated cell sorter
Single-cell suspension was prepared and resuspended in PBS containing 2% fetal calf serum (FCS) and 0.02% NaN3. Cells were stained for 30 min on ice with antibodies (Pharmingen, San Diego, CA, USA) that included the following: anti-CD31-FITC (390), biotinylated anti-VEGFR2 (Avas12a1), anti-CD133-FITC (13A4), anti-CD106-FITC (429MVCAM.A), and streptavidin-APC. Stained cells were washed and analyzed using a fluorescence-activated cell sorter (FACSCalibur; BD Immunocytometry System, San Jose, CA, USA). Dead cells were excluded by propidium iodide gating. Data were analyzed using the CellQuest software.

Bone marrow transplantation
Bone marrow (BM) was flushed from femurs and tibiae, and single-cell suspension was obtained by passing through an 18-gauge needle and filtered with a nylon filter, followed by erythrolysis in a buffer containing 0.14 M NH4Cl. Recipient mice were sublethally irradiated and transfused with 5 x 106 BM cells through a caudal vein. Recipients were analyzed 2 months later.

Experimental CNV assay
Pupils of anesthetized mice were dilated using a compound tropicaide ophthalmic solution (Double Crane Pharmaceutical, Shandong, China). Animals were placed on a Mayo stand, and fundi were visualized using a three-mirror contact lens and sodium hyaluronate. A multifrequency Nd:YAG laser beam (Iris Medical Instruments, Mountain View, CA, USA), with wavelength of 532 nm and power of 140 mW, was delivered to retina for 0.1 s through a slit lamp biomicroscope (Haag-Streit; Mason, OH, USA). Six laser burns were performed in the 2-, 4-, 6-, 8-, 10-, and 12-o’clock positions of the posterior pole around the optic nerve of both eyes. Lesions with subretinal cavitation bubbles or slight hemorrhages in choroids were permitted to further experiments.

The photocoagulation-induced CNV (33) was evaluated by fundus fluorescence angiography (FFA) 1 and 2 wk after the initial laser treatment. Mice were anesthetized and were injected intraperitoneally with 0.1 ml of 2.5% sodium fluorescein (Wuzhou Pharmaceutical, Guangxi, China). Recording of FFA started 3 min after the injection, using a digital imaging system (Heidelberg Engineering, Heidelberg, Germany). Images were captured using a 35 mm Kowa hand-held-fundus camera (Genesis, Tokyo, Japan) at 3, 5, and 8 min after the injection. The presence of an increasing hyperfluorescent lesion in size at the site of laser irradiation was defined as leakage, indicating the incidence of CNV. The percentage of CNV in six laser photocoagulation spots was calculated for each eye.

Histological analysis of CNV lesions was carried out as described above, with serial sections of CNV lesions (~80 sections at 6 µm for each eye). Images were photographed, and data were imported into the Image Pro Plus 5.1 software to analyze the depth and area of CNV lesions.

Matrigel neovascularization assay
Mice were injected subcutaneously with 0.2 ml of heparinized Matrigel (BD Bioscience, San Jose, CA, USA). The animals were sacrificed 5 days later, the gel plugs were carefully recovered by en bloc resection, and each one was divided into half for hemoglobin quantification using the Drabkin method and histology analysis. Some of the gel plugs were fixed and sectioned for H&E staining, as well as for immunohistochemical staining for VEGFR2, as described above.

EC culture
Mice were sacrificed by cervical dislocation, and the aorta was dissected and cut coronally into segments under sterile conditions. The segments were washed and digested in collagenase IV/PBS for 1 h at 37°C. Dispersed cells were washed again and cultured in 24-well plates with Dulbecco’s modified Eagle’s medium supplemented with 20% FCS and endothelial cell growth supplements (BD Bioscience). Cells were characterized by FACS after being stained with anti-CD31, anti-VEGFR2, and anti-CD106. Cells between passages 2 and 5 were used in experiments. For growth curve depiction, cells (5x104) were seeded in 48-well plates and were counted every 2 days.

Reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative analysis
Liver sinus endothelial cells (LSECs) were sorted from mouse liver (400 mg) using anti-LSEC magnetic beads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) following the recommended protocol. Generally, from 1.5 x 108 cells, ~4 x 106 LSEC were enriched with purity >85%, as confirmed by FACS with anti-VEGFR2 and anti-CD31 antibodies. Sorted cells were immediately dissolved in the Trizol reagent (Invitrogen, Carlsbad, CA, USA), and total cellular RNA was prepared according to the manufacturer’s instructions. cDNA was prepared from the total RNA using a reverse-transcription kit from Toyobo (Toyobo Co., Osaka, Japan). cDNA from equal amount of total RNA was diluted 4-, 16-, and 64-fold and was used to amplify target genes by PCR. Real-time PCR was performed using a kit (SYBR Premix EX Taq, TaKaRa) and the ABI PRISM 7300 Real-Time PCR system, with GAPDH as a reference control. Primers used in RT-PCR were as follows: Hes1: 5'-TACCGATCACTAAGTAGCCCTAA and 5'-ATTCTTGCCCTTCGCCTC; Hesr1: 5'-GAGACCGAATCAATAACAGT and 5'-AAAGTCGCCAGTAAGTAAGTCAG; VEGFR1 (flt1): 5'-GTGTGAACGGCTGCCCTATG and 5'-ATCACCATCAGAGGCCCTCC; VEGFR2 (KDR/flk1): 5'-CATTATCCTCGTCGGCACTGC and 5'-TGCTCGCTGTGTGTTGCTCC; and β-actin: 5'-CTGGAGAAGAGCTATGAGCTGG and 5'-CAACGTCACACTTCATGATGG. Primers used for real time RT-PCR included the following: GAPDH: 5'-TCGACAGTCAGCCGCATCTTCTT and 5'-GCGCCCAATACGACCAAATCC; VEGFR2 (KDR/Flk1): 5'-GGGATGGTCCTTGCATCAGAA and 5'-ACTGGTAGCCACTGGTCTGGTTG; Hesr1 (Hey1): 5'-TGAGATCTTGCAGATGACTGTGGA and 5'-CAACTTCGGCCAGGCATTC; p21WAF1: 5'-CTGTCTTGAACTCTGGTGTCTGA and 5'-CCAATCTGCGCTTGGAGTGA; and VEGFR1 (Flt1): 5'-TAATGACGATGGCAACAGGGTAGA and 5'-TGTGCACGACCTAAGCACACAG.

Statistics
Mann-Whitney’s U test was used to compare the leakage score in FFA between RBPf/f-MxCre and the control. Pearson {chi}2 test was used for the CNV production rate. Student’s t test was used for the rest statistical analyses. Values of P < 0.05 were considered statistically significant.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Disruption of RBP-J leads to spontaneous angiogenesis in eye
To study functions of RBP-J in adult vascular maintenance, we used the RBP-J conditional knockout mouse and MxCre transgenic mouse in which Cre expression could be induced by poly(I)-poly(C). We first evaluated Cre activity in ECs of MxCre-ROSA26R mice after systemic administration of poly(I)-poly(C). Four weeks after the induction, significant Cre activity was detected in retinal vasculature (Fig. 1 A) as well as in skin vessels (Supplemental Fig. 1) by X-gal staining.


Figure 1
View larger version (68K):
[in this window]
[in a new window]

 
Figure 1. Knockout of RBP-J leads to spontaneous neovascularization in eye. A) Cre activity in retinal vasculature of MxCre-ROSA26 mice receiving poly(I)-poly(C) injection for 1 month, as shown by β-gal activity. B) Anterior chambers photographed by slit lamp. Blood vessels in the iris (left) and cornea (middle) of RBPf/f-MxCre mice, which could not be seen in RBP+/f-MxCre (right), are indicated by arrows. C) Rhodamine-agglutinin staining of flat-mounted retina. The ring-like spots (arrows) derived from sprouting tiny vessels and filopodia (dots) are marked. D, E) Quantitative analysis of the ring-like spots (D) and filopodia (E) in retina. Four representative x20 fields from a flat-mounted retina of a mouse were analyzed and normalized. Four pairs of RBPf/f-MxCre and control mice were used. Bars = mean ± SD; *P < 0.05; n=16.

Two months after the induction, corneas of RBPf/f-MxCre mice became opaque. Gross observation by a slit lamp exhibited surprising neovascularization in the cornea and iris of RBPf/f-MxCre mice (Fig. 1B ). The formation of retinal vasculature in normal mouse is completed soon after birth and is largely quiescent in adults. We explored the retinal vasculature of RBPf/f-MxCre mice by staining flat-mounted retina with rhodamine-agglutinin. The result showed that compared with RBP+/f-MxCre mice there were a large number of microvessel sprouts growing from the superficial plexus in the retina of RBPf/f-MxCre mice. These neovasculatures grew perpendicularly from the superficial plexus of the retina, forming ring-like structures in the flat-mounted retina under the microscope (Fig. 1C ). Quantification of these ring-like structures (Fig. 1D ), and filopodia (Fig. 1E ) representing the leading edge of angiogenesis, indicated that there was a significant increase of spontaneous angiogenesis in the retinal vasculature in the absence of RBP-J. Therefore, RBP-J may play a role in maintaining vascular homeostasis in adults.

Vascularization of avascular cornea in RBP-J knockout mice
The avascular statue of normal cornea is essential for optical clarity and optimal vision, which is maintained by soluble VEGFR1 (34) . In the RBP-J knockout mouse, remarkable vascularization of cornea was observed (Figs. 1B and 2A) . This was further demonstrated by whole-mount staining of cornea with anti-CD31, an endothelial marker. The result showed that compared with avascular cornea of RBP+/f-MxCre mice the cornea of RBPf/f-MxCre mice was full of CD31+ ECs (Fig. 2 B), with some of them forming cord-like structures (bottom). H&E staining, immunohistochemistry of VEGFR2, as well as SEM, of corneal sections all demonstrated the formation of vessels in corneal stroma (Fig. 2C ). Interestingly, some erythrocytes were leaking out of vessel lumens as seen under SEM (Fig. 2C , bottom), suggesting that the neovasculature formed in the absence of RBP-J was immature. Therefore, in addition to soluble VEGFR1, the signaling mediated by RBP-J might provide another critical pathway in maintaining corneal avascularity.


Figure 2
View larger version (72K):
[in this window]
[in a new window]

 
Figure 2. Vascularization of cornea in RBP-J knockout mice. A) Photographs of corneas from RBPf/f-MxCre and control mice under a bright-field microscope. B) Immunofluorescent staining of flat-mounted corneas from RBPf/f-MxCre and control mice with anti-CD31-FITC. C) H&E staining (top), immunohistochemistry staining with anti-VEGFR2 (middle), and SEM (bottom) of corneal sections from RBPf/f-MxCre and control mice. Diaminobenzidine was used as a chromogen in the immunohistochemical staining; epi = epithelium; str = stroma. Asterisks in H&E and immunohistochemistry staining indicate vessel lumens. Notice that under SEM, there is a small vessel, which is full of erythrocytes and marked by a circle, in the corneal stroma of RBPf/f-MxCre mice.

Increased neovascularization in internal organs of RBP-J knockout mice
We further investigated neovascularization in other organs of RBP-J knockout mice. The mesenchymal structure in the lung of RBP-J knockout mice appeared abnormal, with a remarkable increase of CD31+ signal on immunohistochemical staining (Fig. 3 A, top). Masson’s triple staining exhibited significant accumulation of extracellular matrix that might be derived from ECs (Fig. 3A , middle). SEM confirmed the increased lung mesenchyme (Fig. 3A , bottom), within which a significant increase of capillaries could be seen in RBPf/f-MxCre mice (Fig. 3B ). Similarly, in the liver of RBP-J knockout mice, LSECs increased significantly as shown by immunohistochemical staining with anti-VEGFR2 (Fig. 3C ) and anti-CD31 (data not shown) but not by an isotype control antibody (data not shown). These findings indicated that deficiency of RBP-J might result in extensively spontaneous angiogenesis in adult tissues.


Figure 3
View larger version (70K):
[in this window]
[in a new window]

 
Figure 3. Increased vessel densities in tissues of RBP-J knockout mice. A) Anti-CD31 immunohistochemistry (top), Masson’s triple staining (middle), and SEM (bottom; insets x1000 and x5000) of lung sections from RBPf/f-MxCre and control mice; alv = alveolus; bro = bronchiole; cap = capillary; dia = alveolar diaphragm. Microvessels are indicated by arrows. B) Quantitative analysis of lung microvessels under SEM. Briefly, 2 pieces of lung tissue were randomly selected from each of 4 pairs of mice for SEM. For each sample, the total number of capillaries was counted in 20 alveolar diaphragms, to get the average number of capillaries in one alveolar diaphragm, and was compared between RBPf/f-MxCre mice and RBP+/f-MxCre mice. Bars = mean ± SD; *P < 0.05; n = 8. C) Immunohistochemistry of liver sections with anti-VEGFR2; cv = central veins; p = portal veins.

Disruption of RBP-J induces vascular outgrowth
To further demonstrate that lack of RBP-J induces angiogenesis directly in vivo, we performed a Matrigel plug experiment. Matrigel containing heparin was injected subcutaneously into RBPf/f-MxCre and RBP-J+/f-MxCre mice. Five days later, Matrigel plugs embedded in RBP+/f-MxCre mice were transparent without visible vascularization. However, gel plugs from RBPf/f-MxCre mice were heavily vascularized with severe "tissue" hemorrhage (Fig. 4 A). This was confirmed by measuring the hemoglobin in the gel extracts, which showed a significantly higher amount of hemoglobin in gels from RBPf/f-MxCre mice (Fig. 4B ). Histological analysis indicated that in gel plugs from RBPf/f-MxCre mice there were a large number of VEGFR2+ ECs and vessel lumens filled with blood cells, while few vessels were seen in gel plugs from RBP+/f-MxCre mice (Fig. 4C, D ). These results demonstrated that disruption of RBP-J induced neovascular outgrowth but the neovasculature induced by RBP-J deficiency might be less mature.


Figure 4
View larger version (48K):
[in this window]
[in a new window]

 
Figure 4. Disruption of RBP-J promoted vessel outgrowth. Matrigel was injected subcutaneously into 4 pairs of RBPf/f-MxCre and RBP+/f-MxCre mice, and vascularization of gel plugs was examined 5 days later. A) Gross images of Matrigel plugs. B) Half of gel plugs were homogenized and the hemoglobin concentration of gel extracts was assessed by the Drabkin method. Data are mean ± SD; *P < 0.05 (n=4). C) H&E staining and anti-VEGFR2 immunohistochemistry of gel sections. Filled and open arrows indicate vessels and black brown products of immunohistochemical reactions, respectively. D) Quantitative assessment of VEGFR2-positive capillaries in Matrigel plugs. Four representative microscopic fields were examined in each gel section, and vessel lumens were counted. The average number of lumens in one field was calculated and compared. *P < 0.05; n = 4 pairs of mice.

Enhanced CNV in RBP-J knockout mice
CNV represents the end stage of age-related macular degeneration (AMD), which accounts for most of elderly human blindness in advanced countries. We used the CNV model to determine whether RBP-J plays a role in modulating angiogenic response to injuries. CNV was induced by photocoagulation of retinal pigment epithelium (RPE) and the underlying Bruch’s membrane at multiple spots with a red diode laser. Seven and fourteen days after photocoagulation, neovasculatures penetrated through RPE and the subretinal space to form neovascular complexes, which were characterized by fluorescein leakage detected with FFA. In RBPf/f-MxCre and RBP+/f-MxCre mice, newly formed vascular complexes after the Bruch’s membrane damage extended from the choroid to subretinal space and caused hyperfluorescence on FFA, similar to previous studies (33) . However, CNV lesions in RBPf/f-MxCre mice displayed a significant increase in fluorescence leakage as compared with those of control mice on both day 7 and 14 after photocoagulation, leading to higher frequency of visible neovascular complexes at the irradiated spots (Fig. 5 A, B). Moreover, we sectioned serially CNV lesions on day 14 and estimated the size and depth of CNV lesions after H&E staining. The results revealed that the average CNV area and CNV thickness were significant higher in RBPf/f-MxCre mice than those in RBP+/f-MxCre mice (Fig. 5C, D ). Immunohistochemistry of EC markers (CD31 and VEGFR2) confirmed neovasculatures in the lesions (Supplemental Fig. 2). Interestingly, on day 14 after photocoagulation, compared with in RBP+/f-MxCre mice, we found that the CNV lesions in RBPf/f-MxCre mice had not been encapsulated by pericytes and RPE cells (Fig. 5E ), consistent with the idea that Notch signal may play a role in arteriogenesis (35) . In summary, these data indicated that RBP-J-mediated signaling inhibited angiogenic response to tissue injuries.


Figure 5
View larger version (24K):
[in this window]
[in a new window]

 
Figure 5. CNV assay. A) Representative FFA photos of RBPf/f-MxCre and RBP+/f-MxCre mice 14 days after photocoagulation, which was induced by laser burning and marked by circles. B) Quantification of CNV incidence on days 7 and 14 after photocoagulation. *P < 0.05. C, D) Area (C) and thickness (D) of CNV lesions were compared between 3 pairs of mice (6 eyes in each group). *P < 0.05 (n=6). E) H&E staining of CNV lesions from RBPf/f-MxCre and control mice 2 wk after photocoagulation. CNV lesions were circled by dashed lines. Notice that the CNV lesion of RBPf/f-MxCre mice was not encapsulated compared with that of the control. View x400.

Enhanced CNV in RBP-J knockout mice can be transferred by BM transplantation
In recent years, BM-derived EPCs have been recognized as participants in adult pathological angiogenesis, such as tumor and myocardial infarction, as well as in the incidence and progression of laser-induced CNV (36 , 37) . We thus investigated the effects of RBP-J on EPCs by BM transplantation followed by laser-induced CNV in recipient mice. As shown in Fig. 6 A, incidence of CNV was significantly increased in mice receiving BM from RBPf/f-MxCre mice. By a semiquantitative analysis of fluorescein leakage from CNV lesions on days 7 and 14 after laser photocoagulation, we found that in mice receiving BM from RBPf/f-MxCre mice CNV lesions were significantly promoted (Fig. 6B ). Histological analysis of CNV lesions showed that the CNV area and thickness developed remarkably faster and were more severe than the control (Fig. 6C, D ; Supplemental Fig. 3).


Figure 6
View larger version (22K):
[in this window]
[in a new window]

 
Figure 6. CNV assay in BM transplantation recipient mice. BM cells were harvested from induced RBPf/f-MxCre and control mice and were transfused to irradiated recipient mice (6 mice in each group). Recipients were used for experimental CNV assay 2 months after BM transplantation, as in Fig. 5 . A) CNV incidence. *P < 0.05. B) Fluorescein leakage in mice receiving BM from RBPf/f-MxCre or control mice. Angiographies on days 7 and 14 after photocoagulation were graded in a masked manner by two examiners using reference angiograms. Circles represent the intensity score of fluorescein leakage, which was graded as follows: 0 = no leakage; 1 = slight leakage; 2 = moderate leakage; 3 = prominent leakage. *P < 0.05. Twelve eyes from six mice in each group were analyzed (n=8 and 4 for days 7 and 14, respectively). C, D) CNV thickness and area of 2 groups of irradiated recipient mice. *P < 0.05. E) FACS analysis of EPCs and CECs in peripheral blood of mice receiving BM from RBPf/f-MxCre or control mice. Bars = mean ± SD; *P < 0.05; n = 6.

We further detected EPCs and circulating ECs (CECs) in the peripheral blood of BM-transfused mice by FACS after staining with anti-VEGFR2 and anti-CD31 (CECs) or anti-VEGFR2 and anti-CD133 (EPCs). The results showed that, while the number of EPCs did not change significantly between RBPf/f-MxCre and RBP+/f-MxCre BM-transfused mice, the number of CECs increased greatly in the peripheral blood of mice accepting RBP-J knockout BM (Fig. 6E ; Supplemental Fig. 4). These data suggested that the RBP-J might also affect the differentiation of EPCs.

Interruption of RBP-J induces EC proliferation
RBP-J mediates Notch signaling, which has been demonstrated to induce growth arrest in ECs (38 , 39) . Therefore, we investigated in vivo the proliferation of ECs in RBP-J knockout mice by immunofluorescent staining of PCNA, a marker of proliferating cells. Because it is difficult to count cells after this staining, we analyzed the pictures using the Image Pro Plus 5.1 software by which ECs and PCNA-positive cells were represented by red areas (rhodamine-agglutinin) and green areas (FITC), respectively. The result showed that, in the retinal vasculature of RBP-J knockout mice, the expression of PCNA in ECs was increased remarkably. These proliferating ECs existed both at growing filopodia and vessel trunks of the superficial retinal vasculature (Fig. 7 A, B). Subsequently, we cultured aortic ECs from RBPf/f-MxCre and RBP-J+/f-MxCre mice. These results showed that ECs from RBPf/f-MxCre mice had a significantly higher potential of proliferation (Fig. 7C ). Labeling of the in vitro cultured ECs with 5-carboxyfluorescein diacetate succinimidyl ester (CFSE) and examining cell proliferation also showed that, consistent with the in vivo results, disruption of RBP-J induced ECs proliferation (Fig. 7D ). These findings indicated that RBP-J-mediated signaling induced growth inhibition in ECs.


Figure 7
View larger version (22K):
[in this window]
[in a new window]

 
Figure 7. RBP-J deficiency induced EC proliferation. A) Flat-mounted retinas were double stained with anti-PCNA-FITC and rhodamine-agglutinin. B) Quantitative analysis of immunofluorescence in A. Images were imported into Image Pro Plus 5.1 software to get the sum pixels of red (rhodamine-agglutinin=total vessels) and green (FITC-PCNA=proliferating cells). The total vessels/field (left) and the PCNA+ vessels (right) were compared between RBPf/f-MxCre and control mice. Four pairs of mice were used. *P < 0.05; n = 4. C) Growth curve of in vitro cultured ECs. In each group, cells (5x104) were divided into 15 wells, and 3 wells were counted every 2 days. D) ECs (3x105) were labeled with CFSE and cultured, followed by FACS analysis. E, F) LSECs were immunomagnetic-sorted from RBPf/f-MxCre and control mice, and semiquantitive RT-PCR (E) and real-time RT-PCR (F) with cDNA from total RNA of LSECs were performed.

Up-regulation of VEGFR2 in ECs of RBP-J knockout mice
We further assessed possible molecular mechanisms underlying the growth arrest in RBP-J-deficient ECs, by comparing the expression of critical downstream molecules in LSECs magnetically sorted from RBPf/f-MxCre and RBP+/f-MxCre mice. RBP-J directly regulates Hes-family members (40 , 41) . We found that deficiency of RBP-J led to down-regulation of Hes1 and Hesr1, consistent with published results (42 ; Fig. 7E, F ). Moreover, knockout of RBP-J up-regulated VEGFR2 (Flk1/KDR) expression but down-regulated VEGFR1 (Flt1) mRNA. p21WAF1, a cyclin-dependent kinase (Cdk) inhibitor downstream of Notch signaling, was up-regulated in RBP-J knockout ECs. These results, in combination with published data, suggested that Notch-RBP-J signaling might maintain vascular homeostasis by inhibiting EC proliferation through turning down the VEGFR signaling and influencing the cell cycle.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
The function and mechanism of Notch signaling in early and late embryonic vascular development have been well elucidated, especially by those studies reported recently (43) . However, because loss-of-function mutations of major molecules of the Notch pathway unavoidably result in embryonic lethality, the exact role of Notch signaling in adult vasculature remains obscure, even though a number of in vitro studies have suggested critical roles of Notch signaling in angiogenesis. To solve this issue, we used a conditional loss-of-function mutation of RBP-J, the essential transcription factor mediating signaling of all four Notch receptors in mammals. We have demonstrated that disruption of RBP-J in adult mice results in spontaneous angiogenesis by three pieces of evidence. First, disruption of RBP-J leads to spontaneous angiogenesis in retina and internal organs such as lung and liver. Second, RBP-J knockout results in vascularization of avascular cornea. Third, knockout of RBP-J induces vessel outgrowth into artificial matrices embedded in mouse tissues. Previous studies (18 , 29) have reported that the deletion of RBP-J recapitulates the phenotypes of individual receptor knockouts in the embryonic stage. Until now, Notch-independent functions of RBP-J have not been described in the mammalian system and RBP-J deletion essentially generates a specific blockade of the canonical Notch signaling pathway (21) . Therefore, our results suggest that in normal adults, the Notch-RBP-J pathway provides a repressive signal for angiogenesis, which contributes to homeostasis of normal vasculature.

Destabilization of vascular homeostasis is critical in initiation and progression of many diseases (23) . CNV is a common end-stage process leading to severe visual loss in numerous ocular diseases (44) . In our model, disruption of the Notch signaling resulted in a more severe neovascularization at the site of laser-induced retinal injury. We hypothesized that the intensified CNV response in RBP-J knockout mice may be attributed to at least three mutually unexclusive reasons. One is the increased angiogenesis, as shown by the fact that disruption of Notch signaling induces spontaneous angiogenesis. A second reason might be the increased vasculogenesis. Many research groups have reported that BM-derived EPCs take part in CNV, at least in experimental models. Our results showed that mice receiving BM from RBP-J knockout mice exhibited stronger CNV responses. FACS analyses showed that, despite the fact that the number of EPCs did not change in the recipient mice, CECs indeed increased remarkably in mice receiving BM from RBP-J knockout mice. These results suggest that Notch-RBP-J signaling might be involved in the regulation of EPC-mediated vasculogenesis in adults. Thirdly, immaturity of neovasculature may also contribute to a stronger CNV response in RBP-J knockout mice. It should be noted that in the Matrigel plug assay, even though ECs created prominent lumens filled with blood cells, severe hemorrhages were displayed in the plugs, suggesting that with disrupted RBP-J new lumens would be defective and fail to create a vascular network in proper density and framework. Similar defective lumens were also noticed in vessels formed in corneal stroma in RBP-J knockout mice. Last but not least, CNV is the most severe complication of AMD, which mostly leads to blindness in elderly patients. A recent study (45) has implicated that Notch signaling is involved in age-related disorders. As our results have demonstrated that loss of RBP-J-mediated signaling promotes CNV, it might be interesting to examine dynamics of Notch molecule expression in ECs of different ages so as to figure out whether Notch signaling is involved in human AMD.

How does Notch signaling maintain vascular homeostasis? In mature vasculature, most ECs remain quiescent except for the menstruous ovary. Initiation of angiogenesis involves entry of ECs into cell cycle, proliferation and migration, and re-exits from the cell cycle to form mature vessel lumens. Notch signaling influences cell fate decision, apoptosis and cell proliferation by enabling cell-cell communication between contacting cells. In RBP-J knockout mice, we did not detect alteration in apoptosis compared with control mice (data not shown), suggesting that Notch signaling might not target cell apoptosis in our system. However, by using PCNA staining, we did reveal elevated EC proliferation in RBPf/f-MxCre mice compared with RBP+/f-MxCre mice, supporting previous studies (46 , 47 , 49) using {gamma}-secretase inhibitors, selective antibodies, or soluble antagonists based on ligand-receptor interaction. To confirm these observations, we cultured aortic ECs from RBPf/f-MxCre and RBP+/f-MxCre mice in vitro. RBP-J knockout ECs have remarkable advantage in proliferation, demonstrating that the RBP-J-mediated Notch signaling pathway represses EC proliferation in normal adults. This contact-mediated growth inhibition might be important not only for the maintenance of vascular homeostasis but also for ECs to exit from the cell cycle in the formation of vessel lumens, as we noticed that when cultured for 7 days in vitro, RBP-J-deficient ECs overlaid and stacked to form sheeted structures (data not shown).

Reciprocal interaction between Notch signaling and VEGF-VEGFR signaling has been implicated in ECs (38 , 48 , 49) . Previous in vitro studies (27 , 50) have shown that Notch signaling represses EC proliferation through Hes family members and VEGFR2. Indeed, semiquantitative RT-PCR as well as quantitative real-time PCR showed that in LSECs from RBPf/f-MxCre mice, expression of Hes1 and Hesr1 was significantly reduced. VEGFR2 was up-regulated, consistent with the proliferation phenotype and previous reports. This suggests that in adulthood, Notch-RBP-J signaling maintains vascular homeostasis by repressing EC proliferation possibly through down-regulation of VEGFR2 expression. Of note is that the expression of VEGFR1 is significantly down-regulated in ECs of RBP-J deficient mice. According to studies reported recently by Ambati et al. (34) , soluble VEGFR1 (Flt1) is responsible for maintaining the corneal avascularity by antagonizing proangiogenic functions in cornea. A recent in vitro study (51) indicated the regulative role of Notch signaling on VEGFR1. Our results suggest that Notch-RBP-J signaling may be involved in maintaining the avascularity of cornea by up-regulating the expression of soluble VEGFR1. However, on the other hand, our observation raises another open question, namely how Notch-RBP-J signaling regulates two VEGF receptors in an opposite manner.

Down-regulation of p21WAF1 in ECs has been reported when Notch is activated (39) . Consistently, our quantitative analysis has demonstrated that when RBP-J is deleted, the expression of p21WAF1 is up-regulated. Although up-regulation of p21WAF1 on Notch activation has been implicated in differentiation-associated growth arrest in keratinocytes (52 , 53) , our results suggest that at least in ECs, up-regulation (in this study by RBP-J deletion) of p21WAF1 expression may not be sufficient for growth arrest and subsequent differentiation. This difference may be due to the cell type-specific context, and detailed molecular analyses are required to elucidate the control mechanism for the growth and differentiation of ECs.

A series of recent studies (54) implicated Notch signaling as a new therapeutic target for pathological angiogenesis by the application of agonists or antagonists. Here, our findings demonstrate the essential role of Notch-RBP-J signaling in the maintenance of vascular homeostasis in adults, which will be instructive for developing and administration of such therapies.


   ACKNOWLEDGMENTS
 
We thank H. Wang for critical correction of English of the manuscript. This work was supported by grants from the Natural Science Foundation (30330550, 30672291, 30425015, and 30700415) and the Ministry of Education (IRT0459) of China.


   FOOTNOTES
 
1 These authors contributed equally to this work.

Received for publication October 9, 2007. Accepted for publication November 29, 2007.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6,389-395[CrossRef][Medline]
  2. Roberts, N., Jahangiri, M., Xu, Q. (2005) Progenitor cells in vascular disease. J. Cell. Mol. Med. 9,583-591[Medline]
  3. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., Holash, J. (2000) Vascular-specific growth factors and blood vessel formation. Nature 407,242-248[CrossRef][Medline]
  4. Gridley, T. (2001) Notch signaling during vascular development. Proc. Natl. Acad. Sci. U. S. A. 98,5377-5378[Free Full Text]
  5. Hrabe de Angelis, M., McIntyre, J., 2nd, Gossler, A. (1997) Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 386,717-721[CrossRef][Medline]
  6. Krebs, L. T., Xue, Y., Norton, C. R., Shutter, J. R., Maguire, M., Sundberg, J. P., Gallahan, D., Closson, V., Kitajewski, J., Callahan, R., Smith, G. H., Stark, K. L., Gridley, T. (2000) Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14,1343-1352[Abstract/Free Full Text]
  7. Xue, Y., Gao, X., Lindsell, C. E., Norton, C. R., Chang, B., Hicks, C., Gendron-Maguire, M., Rand, E. B., Weinmaster, G., Gridley, T. (1999) Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8,723-730[Abstract/Free Full Text]
  8. Carlson, T. R., Yan, Y., Wu, X., Lam, M. T., Tang, G. L., Beverly, L. J., Messina, L. M., Capobianco, A. J., Werb, Z., Wang, R. (2005) Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc. Natl. Acad. Sci. U. S. A. 102,9884-9889[Abstract/Free Full Text]
  9. Duarte, A., Hirashima, M., Benedito, R., Trindade, A., Diniz, P., Bekman, E., Costa, L., Henrique, D., Rossant, J. (2004) Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 18,2474-2478[Abstract/Free Full Text]
  10. Fischer, A., Schumacher, N., Maier, M., Sendtner, M., Gessler, M. (2004) The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18,901-911[Abstract/Free Full Text]
  11. Lacombe, P., Oligo, C., Domenga, V., Tournier-Lasserve, E., Joutel, A. (2005) Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke 36,1053-1058[Abstract/Free Full Text]
  12. Leong, K. G., Hu, X., Li, L., Noseda, M., Larrivee, B., Hull, C., Hood, L., Wong, F., Karsan, A. (2002) Activated Notch4 inhibits angiogenesis: role of beta 1-integrin activation. Mol. Cell. Biol. 22,2830-2841[Abstract/Free Full Text]
  13. Nakajima, M., Yuasa, S., Ueno, M., Takakura, N., Koseki, H., Shirasawa, T. (2003) Abnormal blood vessel development in mice lacking presenilin-1. Mech. Dev. 120,657-667[CrossRef][Medline]
  14. Rao, P. K., Dorsch, M., Chickering, T., Zheng, G., Jiang, C., Goodearl, A., Kadesch, T., McCarthy, S. (2000) Isolation and characterization of the notch ligand delta4. Exp. Cell. Res. 260,379-386[CrossRef][Medline]
  15. Swiatek, P. J., Lindsell, C. E., del Amo, F. F., Weinmaster, G., Gridley, T. (1994) Notch1 is essential for postimplantation development in mice. Genes Dev. 8,707-719[Abstract/Free Full Text]
  16. Uyttendaele, H., Ho, J., Rossant, J., Kitajewski, J. (2001) Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc. Natl. Acad. Sci. U. S. A. 98,5643-5648[Abstract/Free Full Text]
  17. Villa, N., Walker, L., Lindsell, C. E., Gasson, J., Iruela-Arispe, M. L., Weinmaster, G. (2001) Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech. Dev. 108,161-164[CrossRef][Medline]
  18. Sainson, R. C., Aoto, J., Nakatsu, M. N., Holderfield, M., Conn, E., Koller, E., Hughes, C. C. (2005) Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J. 19,1027-1029[Abstract/Free Full Text]
  19. Hellstrom, M., Phng, L. K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A. K., Karlsson, L., Gaiano, N., Yoon, K., Rossant, J., Iruela-Arispe, M. L., Kalen, M., Gerhardt, H., Betsholtz, C. (2007) Dll4 signaling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445,776-780[CrossRef][Medline]
  20. Leslie, J. D., Ariza-McNaughton, L., Bermange, A. L., McAdow, R., Johnson, S. L., Lewis, J. (2007) Endothelial signaling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 134,839-844[Abstract/Free Full Text]
  21. Bray, S. J. (2006) Notch signaling: a simple pathway becomes complex. Nat. Rev. Mol. Cell. Biol. 7,678-689[CrossRef][Medline]
  22. Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cecillion, M., Marechal, E., Maciazek, J., Vayssiere, C., Cruaud, C., Cabanis, E. A., Ruchoux, M. M., Weissenbach, J., Bach, J. F., Bousser, M. G., Tournier-Lasserve, E. (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383,707-710[CrossRef][Medline]
  23. Joutel, A., Tournier-Lasserve, E. (1998) Notch signaling pathway and human diseases. Semin. Cell. Dev. Biol. 9,619-625[CrossRef][Medline]
  24. Roy, M., Pear, W. S., Aster, J. C. (2007) The multifaceted role of Notch in cancer Curr. Opin. Genet. Dev. 17,52-59[CrossRef][Medline]
  25. Rehman, A. O., Wang, C. Y. (2006) Notch signaling in the regulation of tumor angiogenesis. Trends Cell Biol. 16,293-300[CrossRef][Medline]
  26. Liu, Z. J., Xiao, M., Balint, K., Soma, A., Pinnix, C. C., Capobianco, A. J., Velazquez, O. C., Herlyn, M. (2006) Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB J. 20,1009-1011[Abstract/Free Full Text]
  27. Taylor, K. L., Henderson, A. M., Hughes, C. C. (2002) Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. Microvasc. Res. 64,372-383[CrossRef][Medline]
  28. Kato, H., Taniguchi, Y., Kurooka, H., Minoguchi, S., Sakai, T., Nomura-Okazaki, S., Tamura, K., Honjo, T. (1997) Involvement of RBP-J in biological functions of mouse Notch1 and its derivatives. Development 124,4133-4141[Abstract]
  29. Krebs, L. T., Shutter, J. R., Tanigaki, K., Honjo, T., Stark, K. L., Gridley, T. (2004) Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 18,2469-2473[Abstract/Free Full Text]
  30. Gridley, T. (2007) Notch signaling in vascular development and physiology. Development 134,2709-2718[Abstract/Free Full Text]
  31. Siekmann, A. F., Lawson, N. D. (2007) Notch signaling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445,781-784[CrossRef][Medline]
  32. Han, H., Tanigaki, K., Yamamoto, N., Kuroda, K., Yoshimoto, M., Nakahata, T., Ikuta, K., Honjo, T. (2002) Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 14,637-645[Abstract/Free Full Text]
  33. Takahashi, H., Yanagi, Y., Tamaki, Y., Uchida, S., Muranaka, K. (2004) COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model. Biochem. Biophys. Res. Commun. 325,461-466[CrossRef][Medline]
  34. Ambati, B. K., Nozaki, M., Singh, N., Takeda, A., Jani, P. D., Suthar, T., Albuquerque, R. J., Richter, E., Sakurai, E., Newcomb, M. T., Kleinman, M. E., Caldwell, R. B., Lin, Q., Ogura, Y., Orecchia, A., Samuelson, D. A., Agnew, D. W., St. Leger, J., Green, W. R., Mahasreshti, P. J., Curiel, D. T., Kwan, D., Marsh, H., Ikeda, S., Leiper, L. J., Collinson, J. M., Bogdanovich, S., Khurana, T. S., Shibuya, M., Baldwin, M. E., Ferrara, N., Gerber, H. P., De Falco, S., Witta, J., Baffi, J. Z., Raisler, B. J., Ambati, J. (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443,993-997[CrossRef][Medline]
  35. Noseda, M., Fu, Y., Niessen, K., Wong, F., Chang, L., McLean, G., Karsan, A. (2006) Smooth muscle alpha-actin is a direct target of Notch/CSL. Circ. Res. 98,1468-1470[Abstract/Free Full Text]
  36. Hou, H. Y., Wang, Y. S., Xu, J. F., Wang, Y. C., Liu, J. P. (2006) The dynamic conduct of bone marrow-derived cells in the choroidal neovascularization microenvironment. Curr. Eye. Res. 31,1051-1061[CrossRef][Medline]
  37. Urbich, C., Dimmeler, S. (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95,343-353[Abstract/Free Full Text]
  38. Lobov, I. B., Renard, R. A., Papadopoulos, N., Gale, N. W., Thurston, G., Yancopoulos, G. D., Wiegand, S. J. (2007) Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc. Natl. Acad. Sci. U. S. A. 104,3219-3224[Abstract/Free Full Text]
  39. Noseda, M., Chang, L., McLean, G., Grim, J. E., Clurman, B. E., Smith, L. L., Karsan, A. (2004) Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Mol. Cell. Biol. 24,8813-8822[Abstract/Free Full Text]
  40. Bailey, A. M., Posakony, J. W. (1995) Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity. Genes Dev. 9,2609-2622[Abstract/Free Full Text]
  41. Kokubo, H., Lun, Y., Johnson, R. L. (1999) Identification and expression of a novel family of bHLH cDNAs related to Drosophila hairy and enhancer of split. Biochem. Biophys. Res. Commun. 260,459-465[CrossRef][Medline]
  42. Iso, T., Chung, G., Hamamori, Y., Kedes, L. (2002) HERP1 is a cell type-specific primary target of Notch. J. Biol. Chem. 277,6598-6607[Abstract/Free Full Text]
  43. Karsan, A. (2005) The role of notch in modeling and maintaining the vasculature. Can. J. Physiol. Pharmacol. 83,14-23[CrossRef][Medline]
  44. Hans, E. G., Richard, W., G. (2004) Choroidal neovascularization. Am. J. Ophtalmol. 137,496-503[CrossRef][Medline]
  45. Carey, K. A., Farnfield, M. M., Tarquinio, S. D., Cameron-Smith, D. (2007) Impaired expression of Notch signaling genes in aged human skeletal muscle. J. Gerontol. A Biol. Sci. Med. Sci. 62,9-17[Abstract/Free Full Text]
  46. Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Lin, H. C., Yancopoulos, G. D., Thurston, G. (2006) Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444,1032-1037[CrossRef][Medline]
  47. Paris, D., Quadros, A., Patel, N., DelleDonne, A., Humphrey, J., Mullan, M. (2005) Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors. Eur. J. Pharmacol. 514,1-15[CrossRef][Medline]
  48. Lawson, N. D., Vogel, A. M., Weinstein, B. M. (2002) Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell 3,127-136[CrossRef][Medline]
  49. Williams, C. K., Li, J. L., Murga, M., Harris, A. L., Tosato, G. (2006) Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 107,931-939[Abstract/Free Full Text]
  50. Henderson, A. M., Wang, S. J., Taylor, A. C., Aitkenhead, M., Hughes, C. C. (2001) The basic helix-loop-helix transcription factor HESR1 regulates endothelial cell tube formation. J. Biol. Chem. 276,6169-6176[Abstract/Free Full Text]
  51. Harrington, L. S., Sainson, R. C., Williams, C. K., Taylor, J. M., Shi, W., Li, J. L., Harris, A. L. (2007) Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvasc. Res. Epub ahead of print
  52. Nicolas, M., Wolfer, A., Raj, K., Kummer, J. A., Mill, P., van Noort, M., Hui, C. C., Clevers, H., Dotto, G. P., Radtke, F. (2003) Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet. 33,416-421[CrossRef][Medline]
  53. Rangarajan, A., Talora, C., Okuyama, R., Nicolas, M., Mammucari, C., Oh, H., Aster, J. C., Krishna, S., Metzger, D., Chambon, P., Miele, L., Aguet, M., Radtke, F., Dotto, G. P. (2001) Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J. 20,3427-3436[CrossRef][Medline]
  54. Thurston, G., Noguera-Troise, I., Yancopoulos, G. D. (2007) The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nature Rev. Cancer 7,327-331[CrossRef][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.07-9998comv1
fj.07-9998comv2
22/5/1606    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dou, G.-R.
Right arrow Articles by Han, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dou, G.-R.
Right arrow Articles by Han, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS